NASDAQ:SLP - Simulations Plus Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $19.50 -0.31 (-1.56 %) (As of 12/13/2018 08:00 AM ET)Previous Close$19.81Today's Range$19.40 - $20.1152-Week Range$14.25 - $23.95Volume27,600 shsAverage Volume64,770 shsMarket Capitalization$345.09 millionP/E Ratio48.32Dividend Yield1.21%Beta-0.71 ProfileDiscussionChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; KIWI, a cloud-based Web application, which organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; and DILIsym, a software that is used to investigate the likelihood that a known drug molecule would cause injury to the liver. Further, the company provides consulting services ranging from early drug discovery through preclinical and clinical trial data analysis, and for submissions to regulatory agencies; and population modeling and simulation contract research services for the pharmaceutical and biotechnology industries. Additionally, it offers its pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, and food companies. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California. Receive SLP News and Ratings via Email Sign-up to receive the latest news and ratings for SLP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer integrated systems design Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:SLP Previous Symbol CUSIPN/A Webwww.simulations-plus.com Phone661-723-7723 Debt Debt-to-Equity RatioN/A Current Ratio3.70 Quick Ratio3.70 Price-To-Earnings Trailing P/E Ratio48.32 Forward P/E Ratio42.39 P/E GrowthN/A Sales & Book Value Annual Sales$29.67 million Price / Sales11.45 Cash Flow$0.6608 per share Price / Cash Flow29.51 Book Value$1.84 per share Price / Book10.60 Profitability EPS (Most Recent Fiscal Year)$0.50 Net Income$8.93 million Net Margins30.11% Return on Equity24.97% Return on Assets17.82% Miscellaneous Employees95 Outstanding Shares17,420,000Market Cap$345.09 million OptionableOptionable Simulations Plus (NASDAQ:SLP) Frequently Asked Questions What is Simulations Plus' stock symbol? Simulations Plus trades on the NASDAQ under the ticker symbol "SLP." How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus? Simulations Plus declared a quarterly dividend on Tuesday, October 23rd. Shareholders of record on Thursday, November 1st will be given a dividend of $0.06 per share on Thursday, November 8th. This represents a $0.24 annualized dividend and a yield of 1.23%. The ex-dividend date is Wednesday, October 31st. View Simulations Plus' Dividend History. How were Simulations Plus' earnings last quarter? Simulations Plus, Inc. (NASDAQ:SLP) released its quarterly earnings data on Wednesday, November, 14th. The technology company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.01. The technology company earned $6.70 million during the quarter, compared to analyst estimates of $5.98 million. Simulations Plus had a return on equity of 24.97% and a net margin of 30.11%. View Simulations Plus' Earnings History. When is Simulations Plus' next earnings date? Simulations Plus is scheduled to release their next quarterly earnings announcement on Tuesday, January 8th 2019. View Earnings Estimates for Simulations Plus. Has Simulations Plus been receiving favorable news coverage? News headlines about SLP stock have trended neutral recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Simulations Plus earned a coverage optimism score of 0.3 on InfoTrie's scale. They also gave news headlines about the technology company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an impact on the company's share price in the near term. Who are some of Simulations Plus' key competitors? Some companies that are related to Simulations Plus include Nextgen Healthcare (NXGN), Sykes Enterprises (SYKE), Unisys (UIS), Onespan (OSPN), Ribbon Communications (RBBN), KEYW (KEYW), Agilysys (AGYS), Digimarc (DMRC), Aerohive Networks (HIVE), Pareteum (TEUM), Borqs Technologies (BRQS), Travelzoo (TZOO), Asure Software (ASUR), CSP (CSPI) and AgriVest Americas (NXCN). Who are Simulations Plus' key executives? Simulations Plus' management team includes the folowing people: Mr. Walter S. Woltosz, Co-Founder & Chairman (Age 73)Mr. Shawn M. O'Connor, Chief Exec. Officer (Age 58)Mr. John R. Kneisel, Chief Financial Officer (Age 60)Ms. Cynthia Walawander, VP of OperationsMs. Virginia E. Woltosz, Sec. & Treasurer (Age 67) Who are Simulations Plus' major shareholders? Simulations Plus' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (4.92%), Renaissance Technologies LLC (3.50%), Vanguard Group Inc. (3.21%), Dimensional Fund Advisors LP (3.15%), William Blair Investment Management LLC (2.41%) and Ancora Advisors LLC (2.13%). Company insiders that own Simulations Plus stock include Argenio David Z D, John Robert Kneisel, Thaddeus Henry Grasela Jr, Virginia E Woltosz and Walter S Woltosz. View Institutional Ownership Trends for Simulations Plus. Which major investors are selling Simulations Plus stock? SLP stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Crawford Investment Counsel Inc., Prudential Financial Inc. and Campbell & CO Investment Adviser LLC. Company insiders that have sold Simulations Plus company stock in the last year include John Robert Kneisel and Walter S Woltosz. View Insider Buying and Selling for Simulations Plus. Which major investors are buying Simulations Plus stock? SLP stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., William Blair Investment Management LLC, First Light Asset Management LLC, Ancora Advisors LLC, Dimensional Fund Advisors LP, Vanguard Group Inc., Cadence Capital Management LLC and Algert Global LLC. View Insider Buying and Selling for Simulations Plus. How do I buy shares of Simulations Plus? Shares of SLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Simulations Plus' stock price today? One share of SLP stock can currently be purchased for approximately $19.50. How big of a company is Simulations Plus? Simulations Plus has a market capitalization of $345.09 million and generates $29.67 million in revenue each year. The technology company earns $8.93 million in net income (profit) each year or $0.50 on an earnings per share basis. Simulations Plus employs 95 workers across the globe. What is Simulations Plus' official website? The official website for Simulations Plus is http://www.simulations-plus.com. How can I contact Simulations Plus? Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company can be reached via phone at 661-723-7723 or via email at [email protected] MarketBeat Community Rating for Simulations Plus (NASDAQ SLP)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 169 (Vote Outperform)Underperform Votes: 201 (Vote Underperform)Total Votes: 370MarketBeat's community ratings are surveys of what our community members think about Simulations Plus and other stocks. Vote "Outperform" if you believe SLP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/13/2018 by MarketBeat.com StaffFeatured Article: What is the Book Value of a Share?